The Mississippi Supreme Court has revived a lawsuit against Bayer AG,
ruling the state can refile a claim the pharmaceutical giant defrauded
its Medicaid program.   The suit accuses Bayer Corp. of inflating
the average wholesale price of medications, causing the state to overpay
drug providers to patients on its Medicaid program. The false price
reports led the Mississippi Medicaid program to spend millions of
taxpayers' dollars unnecessarily.  The state supreme court held that a prior settlement did not resolve the issue, and that this suit can continue.